Mobile Continuing Care Approach for Youth

Addiction Clinical Trial

Official title:

Mobile Continuing Care Approach for Youth

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01632735
• Other study ID #: 5K01DA027754-03
• Secondary ID: 1K01DA027754-01A
• Status: Completed
• Phase: N/A
• First received: June 29, 2012
• Last updated: July 28, 2015
• Start date: February 2012
• Est. completion date: June 2015

Study information

• Verified date: July 2015
• Source: Azusa Pacific University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardUnited States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The primary purpose of this study is to test the effectiveness of a pilot mobile based continuing care program (monitoring/feedback texting) relative to standard continuing care as usual in reducing relapse and improving psychosocial functioning outcomes in a youth population (under 24) with substance abuse problems.

Description:

This study will include approximately 80 participants randomized to either 12 weeks of mobile continuing care (intervention) or standard continuing care as usual (control). Participants will be recruited from the treatment programs in Los Angeles County, including Matrix Institute on Addictions, Tarzana Treatment, Twin Town, Phoenix House, and Cri-Help. During the 12-week active program, participants will be monitored monthly via telephone data collection. Both groups will be followed for 10-months using repeated assessments (self-report and urine specimens) at baseline (month 0) and at follow-up points (months 3, 6, and 9).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: June 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 12 Years to 24 Years

Eligibility

Inclusion Criteria:

1. Youth between 12 and 24 years old

2. Youth in treatment for substance abuse

3. Youth who complete treatment (minimum 12 weeks)

4. Youth who have the cognitive capacity to understand study procedures and agree to participate

Exclusion Criteria:

1. Presence of an adverse (life threatening) medical condition that could interfere with study participation.

2. Presence of psychiatric co-occurring illness or symptoms warranting safety concerns or continued treatment, including acute suicide risk; and

3. Current homelessness (unless residing in recovery home for which contact information can be provided).

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Addiction

Intervention

Behavioral:
• Mobile Continuing Care
Behavioral: Mobile Texting 12-week intervention. Delivers daily Recovering monitoring, self-management feedback, and education/social support

Locations

Country	Name	City	State
United States	Azusa Pacific University Psychology Department	Azusa	California

Sponsors (3)

Lead Sponsor	Collaborator
Azusa Pacific University	National Institute on Drug Abuse (NIDA), University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary Substance Use (Defined as Substance Received Treatment for)	Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).	Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up	No
Secondary	Participation in Recovery Behaviors Over Time	Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.	baseline, discharge, 3-, 6- and 9-month follow-ups	No
Secondary	Recovery Confidence (Self-efficacy) Over Time	Change/improvements in mean recovery confidence score over time (measured by question "How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?" (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).	baseline, discharge, 3-, 6-, and 9-month follow-ups	No
Secondary	Social Support Utilization	Self-help utilization was measured by the question: "In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?"	Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up	No